Blackrock Health Sciences Trust is a US-based company operating in industry. The company is headquartered in Wilmington, Delaware. The company went IPO on 2005-03-29. BlackRock Health Sciences Trust (the Trust) is a closed-end management investment company. The Trust investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry. The Trust seeks to pursue this goal primarily by investing in a portfolio of equity securities and by employing a strategy of writing (selling) call and put options. The Trust invests in a portfolio of sectors, which include pharma, biotech and life sciences; healthcare equipment and services; semiconductors & semiconductor equipment; financial services, and others. BlackRock Advisors, LLC acts as the investment adviser of the Trust.
根據最新的財務報表(Form-10K),Blackrock Health Sciences Trust 的總資產為 $0,淨損失為 $0
BME 的關鍵財務比率是什麼?
Blackrock Health Sciences Trust 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Blackrock Health Sciences Trust 的收入按細分市場或地理位置如何劃分?
Blackrock Health Sciences Trust 最大收入來源為 Control and Sensor Technology Solutions and a Broad Line of Universal Control Systems, Audio-Video Accessories, and Intelligent Wireless Security and Smart Home Products,在最近的收益報告中收入為 420,457,000。就地區而言,United States 是 Blackrock Health Sciences Trust 的主要市場,收入為 129,527,999。
Blackrock Health Sciences Trust 是否盈利?
無,根據最新的財務報表,Blackrock Health Sciences Trust 的淨損失為 $0